Compounds > (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride
Page last updated: 2024-08-17

(4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride and Anaplastic Astrocytoma

(4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride has been researched along with Anaplastic Astrocytoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sastry, BV; Stephan, CC1
Brown, JH; Goldstein, D; Masters, SB1

Other Studies

2 other study(ies) available for (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride and Anaplastic Astrocytoma

ArticleYear
Characterization of the subtype of muscarinic receptor coupled to the stimulation of phosphoinositide hydrolysis in 132-1N1 human astrocytoma cells.
    Cellular and molecular biology (Noisy-le-Grand, France), 1992, Volume: 38, Issue:7

    Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Astrocytoma; Atropine; Carbachol; Diamines; Humans; Hydrolysis; Parasympathomimetics; Phosphatidylinositols; Piperidines; Pirenzepine; Receptors, Muscarinic; Scopolamine; Tumor Cells, Cultured

1992
The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells.
    Molecular pharmacology, 1985, Volume: 27, Issue:5

    Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Astrocytoma; Benzodiazepinones; Carbachol; Cells, Cultured; Chick Embryo; Hydrolysis; Myocardium; Parasympatholytics; Phosphatidylinositols; Pirenzepine; Pyrrolidines; Quaternary Ammonium Compounds; Receptors, Muscarinic

1985